This transaction will further the market-leading position of Eurofins by expanding its reach into the consumer genetics and health and wellness markets. A series of four add-on acquisitions saw DDC further penetrate European markets as well as diversify its product offering into medically led consumer testing, home healthcare and fertility. Significant investment was made in the operating infrastructure of the business to build an organization established in delivering consistent year on year growth. In partnership with GHO, DDC experienced strong growth both organically and through strategic acquisitions. The Company, with approximately 240 employees, will continue to operate from its existing Fairfield, OH facility. In response to the global pandemic, DDC demonstrated its strength and resilience through new product launches and partnerships, with revenue increasing in excess of $55M in 2021.